+
Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Diagnosing ALS: a surprisingly arduous hike lasting 150 years

We introduce a diagnostic biomarker for amyotrophic lateral sclerosis that distinguishes it from similar conditions by examining a combination of plasma proteins. This innovation also offers insights into the underlying mechanisms of the disease, highlighting a compensatory process in skeletal muscle and bioenergetics that seems to start much earlier than previously thought.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Diagnosing ALS through plasma protein analysis.

References

  1. Charcot, J. M. De la sclérose latérale amyotrophique. Le Progrès medical 2, 325–327 (1874). This paper was the first report describing ALS.

    Google Scholar 

  2. Chiò, A. & Traynor, B. J. Biomarkers for ALS—in search of the promised land. Nat. Rev. Neurol. 11, 72–74 (2014). A review that presents a snapshot of biomarkers in ALS.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Akçimen, F. et al. Amyotrophic lateral sclerosis: translating genetic discoveries into therapies. Nat. Rev. Genet. 24, 642–658 (2023). A review that presents recent advances in the genetics of ALS.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Piemonte and Valle d’Aosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology 56, 239–244 (2001). A paper that describes the population-based cohort of ALS in northern Italy.

    Article  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Chia, R. et al. A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis. Nat. Med. https://doi.org/10.1038/s41591-025-03890-6 (2025).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Diagnosing ALS: a surprisingly arduous hike lasting 150 years. Nat Med 31, 3266–3267 (2025). https://doi.org/10.1038/s41591-025-03989-w

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41591-025-03989-w

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载